The depo shot lawsuit is gaining serious traction heading into 2026, with hundreds of women alleging that Depo-Provera injections caused meningioma brain tumors. Pfizer, the manufacturer, faces mounting legal pressure as medical research continues to strengthen the link between the contraceptive shot and tumor growth.
If you used Depo-Provera and were diagnosed with a meningioma, this article breaks down everything you need to know. You’ll find current case updates, estimated settlement amounts, eligibility criteria, filing deadlines, and step-by-step guidance for joining the litigation.
One striking detail stands out. A 2024 BMJ study found that prolonged use of injectable progestins like Depo-Provera increased meningioma risk by up to 5.6 times. That single finding has reshaped the legal strategy for plaintiffs nationwide.
This is a fast-moving case. The information here reflects the most current developments as of 2026.
What Is the Depo Shot Lawsuit About
The depo shot lawsuit is a growing body of litigation against Pfizer alleging that Depo-Provera causes meningioma brain tumors. Plaintiffs claim Pfizer knew about this risk and failed to adequately warn patients or doctors.
Depo-Provera is an injectable contraceptive containing medroxyprogesterone acetate, a synthetic progestin. Women receive the shot every three months to prevent pregnancy. It’s been on the market since 1992 and has been used by millions worldwide.
The lawsuits center on one core accusation: failure to warn. Plaintiffs argue that Pfizer had access to studies linking progestins to meningioma growth for years. Despite this data, the company did not update its warning labels to reflect the brain tumor risk.
Think of it like a car manufacturer knowing the brakes fail in rain but never issuing a recall. The product stayed on shelves while the danger kept growing. That’s the essence of these claims.
| Detail | Info |
|---|---|
| Product | Depo-Provera (medroxyprogesterone acetate) |
| Manufacturer | Pfizer Inc. |
| Primary Allegation | Failure to warn about meningioma risk |
| Tumor Type | Meningioma (typically benign brain tumor) |
| Litigation Type | Mass tort / MDL |
Most lawsuits were filed by women who used Depo-Provera for a year or longer. Many were diagnosed with meningiomas that required surgery, radiation, or ongoing monitoring.
The stakes are high. Even benign meningiomas can cause seizures, vision loss, and permanent neurological damage depending on their location in the brain.
Depo Shot Lawsuit 2026: Where Things Stand Right Now
As of 2026, the depo shot lawsuit is in active litigation with cases being consolidated through the federal court system. No global settlement has been reached yet, but the legal infrastructure is firmly in place.
The U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated Depo-Provera brain tumor cases into a single MDL in late 2024. This consolidation means all federal cases are handled by one judge, which speeds up pretrial proceedings like discovery and expert witness challenges.
Hundreds of individual lawsuits have been filed across multiple states. New cases continue to be added to the MDL on a rolling basis throughout 2026.
Bellwether trials are the next major milestone. These are test cases selected to represent the broader pool of plaintiffs. Their outcomes often push both sides toward settlement negotiations.
| 2026 Milestone | Expected Timing |
|---|---|
| MDL Discovery Phase | Ongoing through mid-2026 |
| Expert Witness Reports | Q2 2026 |
| Bellwether Case Selection | Mid-to-late 2026 |
| Bellwether Trials | Late 2026 or early 2027 |
| Settlement Talks | Likely after bellwether outcomes |
Pfizer has not publicly acknowledged liability. The company maintains that Depo-Provera’s labeling was adequate. That position will be tested once bellwether trials begin.
For plaintiffs, 2026 is a critical year. The decisions made in this litigation window will shape whether a mass settlement becomes realistic.
Depo Shot Brain Tumor Lawsuit and the Meningioma Connection
The depo shot brain tumor lawsuit is specifically about meningiomas, a type of tumor that develops in the membranes surrounding the brain and spinal cord. Medical research has drawn a direct line between Depo-Provera use and increased meningioma risk.
Meningiomas are often described as “benign,” but that word is misleading. These tumors grow inside your skull. Even when noncancerous, they can compress brain tissue and cause debilitating symptoms.
Symptoms linked to meningiomas include:
- Chronic headaches that worsen over time
- Vision changes or partial blindness
- Seizures with no prior history
- Memory loss and cognitive decline
- Weakness in arms or legs
- Hearing loss in some cases
The connection to Depo-Provera comes down to hormones. Meningiomas have progesterone receptors on their surface. When a patient receives large doses of synthetic progestin every three months, those receptors can fuel tumor growth.
A landmark French study published in 2024 examined over 100,000 women using progestins. It found that those using injectable forms like Depo-Provera had a significantly elevated risk of developing meningiomas compared to women who never used the drug.
This isn’t a fringe theory. The FDA itself updated Depo-Provera’s prescribing information in 2024 to include meningioma as a potential risk. That label change came decades after the drug first hit the market.
Key Takeaway: The link between Depo-Provera and meningioma brain tumors is supported by multiple medical studies, and the FDA’s own label update in 2024 strengthened plaintiffs’ legal claims heading into 2026.
Depo Shot Lawsuit Update 2026: Key Dates and Milestones
The most important depo shot lawsuit update for 2026 is that the MDL is progressing through discovery while bellwether trial candidates are being identified. This phase determines the pace of everything that follows.
Discovery is the stage where both sides exchange evidence. Pfizer must hand over internal documents, emails, research data, and communications about meningioma risks. Plaintiffs’ attorneys are looking for evidence that Pfizer knew about the danger earlier than it disclosed.
Several key dates matter for people tracking this case in 2026:
| Event | Projected Date |
|---|---|
| Completion of Document Discovery | Q1 to Q2 2026 |
| Plaintiff Fact Sheet Submissions | Rolling through 2026 |
| Daubert Hearings (Expert Challenges) | Q2 to Q3 2026 |
| Bellwether Pool Selection | Q3 2026 |
| First Bellwether Trial | Late 2026 or Q1 2027 |
Daubert hearings are worth watching closely. These hearings determine whether expert witnesses can present their testimony at trial. If the judge allows plaintiffs’ medical experts to testify about the meningioma connection, it significantly strengthens the case.
Pfizer will likely try to exclude certain studies or experts. This is standard defense strategy in pharmaceutical litigation.
The outcome of bellwether trials typically sets the tone. If juries side with plaintiffs and award substantial damages, Pfizer faces enormous pressure to negotiate a global settlement rather than fight thousands of individual cases.
Depo Shot Settlement Amounts: How Much Could You Get
Depo shot settlement amounts have not been officially determined yet because no settlement has been finalized as of 2026. However, legal analysts and mass tort attorneys have projected potential payout ranges based on comparable pharmaceutical cases.
Individual settlement values will vary dramatically depending on injury severity. A woman who needed brain surgery will receive far more than someone whose meningioma is being monitored without intervention.
Here are projected settlement tiers based on similar mass tort outcomes:
| Injury Level | Description | Estimated Payout Range |
|---|---|---|
| Tier 1 (Severe) | Meningioma requiring surgery, lasting neurological damage | $300,000 to $750,000+ |
| Tier 2 (Moderate) | Meningioma requiring surgery, full or partial recovery | $150,000 to $350,000 |
| Tier 3 (Lower Moderate) | Meningioma treated with radiation, no surgery | $75,000 to $175,000 |
| Tier 4 (Mild) | Meningioma diagnosed, active monitoring, no surgery yet | $25,000 to $75,000 |
These are estimates only. Actual amounts depend on settlement negotiations, trial outcomes, and the total number of qualified claimants.
Comparable cases provide some context. Zantac (ranitidine) cancer lawsuits and talcum powder litigation both produced settlements ranging from tens of thousands to several hundred thousand per plaintiff, depending on injury severity.
One critical factor affects your potential payout: how long you used Depo-Provera. Longer use periods correlate with stronger claims because the cumulative hormone exposure is greater.
What Determines Your Depo Shot Lawsuit Payout
Your depo shot lawsuit payout depends on several factors that attorneys and settlement administrators evaluate on a case-by-case basis. The biggest driver is the severity of your medical injury.
Not all meningioma cases are equal in the eyes of the law. Someone who lost vision permanently after tumor removal stands to recover more than someone whose small tumor was caught early through a routine scan.
Factors that influence your payout include:
- Tumor size and location in the brain
- Whether surgery was required and the complexity of that surgery
- Permanent neurological damage such as vision loss, hearing loss, or cognitive impairment
- Duration of Depo-Provera use (longer use strengthens causation)
- Age at diagnosis (younger plaintiffs may receive more for lifetime impact)
- Lost wages and earning capacity due to medical treatment
- Medical expenses including surgery, rehabilitation, and ongoing monitoring
- Pain and suffering assessed by the nature of treatment endured
Your medical records do the heavy lifting here. They connect the dots between Depo-Provera use and your diagnosis.
It’s similar to car accident claims. A fender bender gets a small settlement. A collision that leaves someone paralyzed gets a much larger one. The principle is the same in pharmaceutical litigation.
Attorney fees typically range from 33% to 40% of your settlement under contingency agreements. Make sure you understand your fee arrangement before signing.
Key Takeaway: Your individual payout depends on tumor severity, duration of Depo-Provera use, and the extent of your medical damages, so gathering complete medical records early is one of the smartest moves you can make.
Is the Depo Shot Lawsuit a Class Action
The depo shot class action lawsuit label is commonly searched, but the litigation is technically a mass tort, not a class action. The distinction matters because it changes how your case is handled and how much you could receive.
In a class action, one lawsuit represents everyone. All class members receive the same payout or follow the same formula. In a mass tort, each plaintiff files an individual claim. Your specific injuries, medical history, and damages determine your settlement value.
| Feature | Class Action | Mass Tort (Depo Shot) |
|---|---|---|
| Individual Assessment | No | Yes |
| Payout Varies by Plaintiff | Rarely | Yes |
| One Lawyer Represents All | Yes | Each plaintiff has own attorney |
| Claims Filed Individually | No | Yes |
| Settlement Based on Your Damages | No | Yes |
The Depo-Provera litigation is proceeding as a mass tort through multidistrict litigation (MDL). Cases are consolidated for pretrial efficiency, but each person’s claim is evaluated individually.
This structure benefits plaintiffs with serious injuries. If you had brain surgery and permanent side effects, your claim is worth significantly more than someone with a small, monitored tumor. A class action would lump everyone together.
Some attorneys may still use the phrase “class action” in their marketing because it’s what people search for. Just know that your case is individual, and your outcome depends on your specific facts.
Who Filed the Lawsuit Against the Depo Shot and Why
The lawsuit against the depo shot was filed by women across the United States who developed meningioma brain tumors after receiving Depo-Provera injections. They allege that Pfizer and its predecessors failed to warn about the risk.
Pfizer acquired the Depo-Provera product line through its merger with Pharmacia & Upjohn Company. Both entities are named as defendants in many of these lawsuits. The core legal theory is product liability based on failure to warn.
Plaintiffs argue three main points:
- Pfizer knew or should have known that Depo-Provera’s progestin could stimulate meningioma growth
- Pfizer failed to update warning labels despite mounting scientific evidence
- Pfizer did not inform healthcare providers about the brain tumor risk, preventing informed consent
Internal company documents are central to these claims. Plaintiffs’ attorneys believe discovery will reveal that Pfizer had early knowledge of the meningioma connection.
The lawsuits began gaining momentum after the BMJ published its 2024 study showing the elevated risk. That study, combined with France’s decision to restrict certain progestin-based drugs, created a wave of public awareness.
Hundreds of women have now filed claims. Many describe similar experiences: years of Depo-Provera injections followed by headaches, vision problems, and eventually an MRI revealing a meningioma tumor.
Depo Provera Meningioma Lawsuit: The Medical Evidence
The Depo Provera meningioma lawsuit relies heavily on scientific research showing that synthetic progestins promote meningioma tumor growth. This evidence forms the backbone of every plaintiff’s case.
Meningiomas contain progesterone receptors. When exposed to high levels of progestins, these receptors can trigger cell proliferation. Depo-Provera delivers a concentrated dose of medroxyprogesterone acetate every 12 weeks, creating sustained hormone exposure.
Key studies supporting the litigation:
- BMJ 2024 Study: Found that women using injectable progestins like Depo-Provera had up to a 5.6 times higher risk of meningioma compared to non-users
- French ANSM Study (2023): Led France to restrict certain progestin medications due to meningioma risk
- WHO Research (ongoing): The World Health Organization has classified medroxyprogesterone acetate as warranting further safety review
- Multiple case reports: Published in neurosurgery journals documenting meningioma regression after Depo-Provera was discontinued
The FDA updated Depo-Provera’s prescribing information in 2024 to include meningioma as a risk. This was the first time the label reflected the brain tumor connection in the U.S. market.
That label change is a powerful piece of evidence. It essentially confirms what plaintiffs have been arguing: the risk was real, and the old labels didn’t reflect it.
Key Takeaway: Multiple peer-reviewed studies and the FDA’s own 2024 label update support the connection between Depo-Provera and meningioma, giving plaintiffs in the 2026 litigation a strong scientific foundation.
Depo Shot Lawsuit Eligibility: Who Qualifies to File
Depo shot lawsuit eligibility requires that you used Depo-Provera and were subsequently diagnosed with a meningioma brain tumor. Meeting both conditions is the baseline, but additional factors strengthen your claim.
Not everyone who received the shot qualifies. And not every brain tumor meets the criteria. The litigation specifically targets meningiomas linked to progestin exposure from Depo-Provera injections.
General eligibility criteria include:
- Received at least two Depo-Provera injections (six months of use minimum)
- Diagnosed with a meningioma (confirmed by MRI, CT scan, or biopsy)
- Diagnosis occurred during or after Depo-Provera use
- Have medical records documenting both the injections and the tumor diagnosis
- Filed within your state’s statute of limitations window
| Eligibility Factor | Stronger Claim | Weaker Claim |
|---|---|---|
| Duration of Use | 2+ years | Less than 6 months |
| Tumor Treatment | Surgery required | Monitoring only |
| Permanent Effects | Vision loss, cognitive damage | Full recovery |
| Medical Records | Complete records available | Gaps in documentation |
| Timing | Diagnosis during or shortly after use | Diagnosis 20+ years later |
Women who used Depo-Provera for several years generally have the strongest claims. The longer the exposure period, the easier it is to argue that the drug caused the tumor.
If a family member died from a meningioma after Depo-Provera use, wrongful death claims may be possible in some states. This depends on state-specific laws and the availability of medical records.
How to File a Depo Shot Lawsuit in 2026
How to file a depo shot lawsuit starts with contacting a mass tort attorney who is accepting Depo-Provera cases. Most attorneys handling these claims work on contingency, meaning you pay nothing upfront.
The filing process follows a general sequence. Each step builds on the previous one, and your attorney handles most of the legal heavy lifting.
Step-by-step filing process:
- Contact an attorney experienced in pharmaceutical mass tort litigation
- Complete a case evaluation (free with most firms; takes 15 to 30 minutes)
- Gather your medical records showing Depo-Provera injections and meningioma diagnosis
- Sign a retainer agreement outlining contingency fee terms
- Your attorney files the complaint in federal court, joining the MDL
- Submit a Plaintiff Fact Sheet (PFS) detailing your medical history and damages
- Participate in discovery if your case is selected for bellwether proceedings
- Await settlement negotiations or trial outcome
Medical records are the single most important piece of evidence. Without documentation of both the injections and the diagnosis, it’s extremely difficult to move forward.
Many women received Depo-Provera years ago and worry that records may be unavailable. Your attorney can request records from pharmacies, clinics, and insurance companies. Even partial records can sometimes support a claim.
The process doesn’t happen overnight. Mass tort cases take time. But filing sooner rather than later protects your legal rights, especially as statute of limitations deadlines approach.
Depo Shot Side Effects That Support a Lawsuit
Depo shot side effects beyond meningioma may strengthen your lawsuit claim by demonstrating a pattern of harm from the drug. While the litigation focuses on brain tumors, other side effects provide supporting context.
The primary side effect driving lawsuits is meningioma. But plaintiffs often report additional symptoms that began during or after Depo-Provera use. Documenting these symptoms helps establish a timeline of injury.
Side effects commonly cited in Depo-Provera lawsuits:
- Meningioma brain tumors (the central claim)
- Chronic severe headaches often misdiagnosed for years
- Vision disturbances including blurred or double vision
- Seizures with no other medical explanation
- Bone density loss (osteoporosis risk)
- Irregular bleeding or prolonged spotting
- Weight gain of 10 or more pounds
- Depression and mood changes
- Fatigue that doesn’t resolve with rest
Many women in the litigation describe a frustrating experience. They visited doctors repeatedly for headaches and vision problems. Years passed before anyone ordered an MRI that revealed a meningioma.
That delay in diagnosis matters legally. If Pfizer had warned about the tumor risk earlier, doctors might have screened for meningiomas sooner. Earlier detection could have prevented the need for invasive surgery.
The failure-to-warn claim gains power when you can show that your symptoms were present, went unexplained, and could have been caught earlier with proper labeling.
Key Takeaway: While meningioma is the central injury, documenting all related side effects like chronic headaches, vision changes, and seizures strengthens your lawsuit by establishing a complete picture of harm.
Depo Provera Brain Tumor Settlement: What to Expect
A Depo Provera brain tumor settlement has not been finalized as of 2026, but the litigation is following a path that typically leads to negotiated settlements in mass tort cases. Here’s what the timeline could look like.
Mass tort pharmaceutical settlements rarely happen before bellwether trials. These early test cases give both sides a reality check. If juries award large verdicts to plaintiffs, Pfizer’s incentive to settle the remaining cases increases dramatically.
Based on how similar pharmaceutical mass torts have played out, here’s a projected timeline:
| Phase | Estimated Timing |
|---|---|
| Bellwether Trials | Late 2026 to early 2027 |
| Initial Settlement Discussions | 2027 |
| Global Settlement Framework | 2027 to 2028 |
| Claims Filing Window | 2028 (if settlement is reached) |
| First Payouts | 2028 to 2029 |
These projections assume the litigation follows a typical mass tort trajectory. Unexpected developments could accelerate or delay the process.
Settlement funding is an option for plaintiffs who need financial support while waiting. Pre-settlement funding companies advance money against your expected payout. The catch: they charge fees and interest that reduce your final amount.
If Pfizer decides not to settle and fights every case individually, the timeline extends significantly. That scenario is less common in pharmaceutical litigation because the cost of defending thousands of individual trials is enormous.
The most likely outcome is a structured settlement with tiered payouts based on injury severity. Plaintiffs with the most severe injuries get paid first and receive the largest amounts.
Depo Shot MDL Update: Multidistrict Litigation Explained
The depo shot MDL is the federal consolidation of all Depo-Provera brain tumor lawsuits into a single court for pretrial proceedings. MDL stands for multidistrict litigation, and it’s the standard process for handling mass tort pharmaceutical cases.
The JPML (Judicial Panel on Multidistrict Litigation) transferred Depo-Provera cases into an MDL to avoid duplicative discovery across dozens of federal courts. One judge now oversees all pretrial matters, which creates consistency and efficiency.
Here’s how the MDL structure works:
| MDL Component | What It Means |
|---|---|
| Consolidation | All federal cases heard by one judge |
| Discovery | Shared evidence exchange (saves time and money) |
| Bellwether Trials | Test cases tried first to gauge outcomes |
| Individual Cases Preserved | Each claim retains its own facts and damages |
| Remand | After MDL, unsettled cases return to original courts |
The MDL does not merge your case with anyone else’s. Your individual facts, medical history, and damages remain yours. The MDL simply handles shared pretrial work more efficiently.
In 2026, the MDL is in its discovery and case management phase. Both sides are exchanging documents, deposing witnesses, and preparing expert reports.
If you’re filing a new case, it will likely be transferred into the MDL automatically. Your attorney handles this process. You don’t need to appear in the MDL court yourself during pretrial proceedings.
Depo Shot Lawsuit Deadline: Statutes of Limitations by State
The depo shot lawsuit deadline depends on your state’s statute of limitations for personal injury and product liability claims. Missing this deadline means losing your right to file, no matter how strong your case is.
Statutes of limitations vary by state. Most states give you two to three years from the date you discovered (or should have discovered) that Depo-Provera caused your injury. This “discovery rule” is critical because many women didn’t learn about the meningioma connection until recently.
| State | Statute of Limitations | Discovery Rule |
|---|---|---|
| California | 2 years | Yes |
| Texas | 2 years | Yes |
| New York | 3 years | Yes |
| Florida | 2 years | Yes |
| Illinois | 2 years | Yes |
| Pennsylvania | 2 years | Yes |
| Ohio | 2 years | Yes |
| Georgia | 2 years | Yes |
The discovery rule may extend your deadline. If you were diagnosed with a meningioma in 2024 but didn’t learn about the Depo-Provera connection until 2025, the clock might start from 2025 in many states.
Don’t assume you’ve missed the deadline without checking. An attorney can evaluate your specific timeline based on when you were diagnosed, when you learned about the link, and which state’s laws apply to your case.
Every month you wait creates risk. Medical records become harder to obtain over time. Witnesses’ memories fade. Filing sooner protects your claim.
Key Takeaway: Statutes of limitations vary by state and typically run two to three years from when you discovered the connection between Depo-Provera and your brain tumor, so checking your specific deadline now is essential.
Filing a Lawsuit for the Depo Shot: Practical Next Steps
Filing a lawsuit for the depo shot in 2026 comes down to preparation and timing. The earlier you organize your information and connect with an attorney, the smoother the process goes.
Here are the practical steps you should take right now:
Gather your medical records. Request records from every provider who administered your Depo-Provera injections. Get records from the facility that diagnosed your meningioma. Include surgical reports, imaging results, and pathology reports.
Create a personal timeline. Write down the approximate dates of your Depo-Provera injections. Note when your symptoms started. Record when your meningioma was diagnosed. This timeline helps your attorney build your case.
Document your damages. Keep records of:
- Medical bills related to your meningioma
- Lost wages from time off work
- Receipts for travel to medical appointments
- Notes about how the tumor affected your daily life
Contact a mass tort attorney. Look for firms with experience in pharmaceutical litigation. Most offer free case evaluations. Contingency arrangements mean you pay nothing unless you win.
Don’t post about your case on social media. Defense attorneys monitor online posts. Anything you say publicly can be used to challenge your claims. Keep your case details private.
The process takes patience. Mass tort cases move slowly. But each step you take now puts you in a stronger position when settlement negotiations or trial dates arrive.
Your medical records are your strongest weapon. Treat them like gold. Make copies. Store them securely. Share them only with your attorney.
Frequently Asked Questions
Can I still file a Depo shot lawsuit in 2026?
Yes, you can still file a Depo shot lawsuit in 2026 if you meet the eligibility requirements and your state’s statute of limitations has not expired.
Most states apply a discovery rule, meaning the clock starts when you learned about the connection between Depo-Provera and meningioma.
Contact an attorney promptly to confirm your specific deadline.
How much money could I get from a Depo shot settlement?
Estimated settlement amounts range from $25,000 to $750,000 or more, depending on the severity of your injury.
Women who required brain surgery and suffered permanent damage are projected to receive the highest payouts.
No official settlement amounts have been set because the litigation is still ongoing in 2026.
Does the Depo shot really cause brain tumors?
Medical research, including a major 2024 BMJ study, found that Depo-Provera use increases meningioma risk by up to 5.6 times.
The FDA updated the drug’s prescribing label in 2024 to include meningioma as a potential risk.
The scientific evidence is strong enough to support hundreds of active lawsuits.
Is the Depo shot lawsuit a class action or mass tort?
The Depo shot litigation is a mass tort, not a class action.
Each plaintiff files an individual claim, and settlement values are based on each person’s specific injuries and damages.
Cases are consolidated in a federal MDL for pretrial efficiency, but each claim remains separate.
What evidence do I need to file a Depo shot brain tumor lawsuit?
You need medical records showing both your Depo-Provera injections and your meningioma diagnosis.
Supporting evidence includes imaging results (MRI or CT scans), surgical reports, pathology reports, and documentation of related symptoms.
Records of medical expenses and lost wages also strengthen your claim.
The Depo shot lawsuit in 2026 is a real and active litigation with growing momentum. If you used Depo-Provera and were diagnosed with a meningioma, your window to act is open right now.
Gather your medical records. Check your state’s filing deadline. Talk to an attorney who handles pharmaceutical mass tort cases.
This is not a situation where waiting helps you. Every day that passes brings you closer to a potential statute of limitations cutoff. Take the first step today.
